Evidence map›Paper›PMID 26503951›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.

Wipawee Wongchana, Rebecca G Lawlor, Barbara A Osborne, Tanapat Palaga

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. OiScience · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Targeting Notch-Activated M1 Macrophages Attenuates Joint Tissue Damage in a Mouse Model of Inflammatory Arthritis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Wipawee WongchanaGraduate Program in Biotechnology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand;
Rebecca G LawlorDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA 01003;
Barbara A OsborneDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA 01003; Molecular and Cellular Biology Program, University of Massachusetts, Amherst, MA 01003;ORCID http://orcid.org/0000-0001-8255-0556
Tanapat PalagaDepartment of Microbiology, Faculty of Science, Omics Sciences and Bioinformatics Center, Chulalongkorn University, Bangkok 10330, Thailand; and Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok 10330, Thailand tanapat.p@chula.ac.th.
Chulalongkorn University · THUniversity of Massachusetts Amherst · US

Funding

Targeting y-secretase in GVHDP01CA166009 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI MIELE, LUCIO · 2013 to 2017
$4.9M
Notch and TLRs Cross Paths in the Innate Immune SystemR03TW008420 · FIC · UNIVERSITY OF MASSACHUSETTS AMHERST · PI OSBORNE, BARBARA A · 2010 to 2012
$165k
FIC NIH HHS R03 TW008420NCI NIH HHS P01 CA166009
6 · The paper itself

Abstract

Notch signaling is involved in regulating TLR-mediated responses in activated macrophages. In this study, we investigated the impact of Notch signaling in macrophages in an experimental autoimmune encephalomyelitis (EAE) model. To examine the impact of deficiency in Notch signaling in activated macrophages in EAE, an adoptive transfer of activated macrophages derived from Notch1(fl/fl) × Mx1cre(+/-) (Notch1 knockout [N1KO]) or CSL/Rbp-jκ(fl/fl) × Mx1cre(+/-) (CSL/RBP-Jκ KO) mice was performed prior to induction of EAE. Mice receiving activated N1KO macrophages showed decreased severity of EAE compared with mice receiving wild-type or CSL/RBP-Jκ KO macrophages. In vitro restimulation of splenocytes by myelin oligodendrocyte glycoprotein 35-55 peptide from these mice revealed that cells from mice receiving N1KO macrophages produced significantly less IL-17 compared with the control mice, whereas IFN-γ production was similar in both groups. We found that activated N1KO, but not CSL/RBP-Jκ KO, macrophages produced less IL-6 and had lower CD80 expression compared with wild-type and did not exhibit any defect in IL-12p40/70 production, whereas activated macrophages from CSL/RBP-Jκ KO mice phenocopied γ-secretase inhibitor treatment for reduced IL-12p40/70 production. Furthermore, the nuclear translocation of the NF-κB subunit c-Rel was compromised in γ-secretase inhibitor-treated and CSL/RBP-Jκ KO but not N1KO macrophages. These results suggest that Notch1 and CSL/RBP-Jκ in macrophages may affect the severity of EAE differently, possibly through modulating IL-6 and CD80 expression, which is involved in the Th17 but not Th1 response.

Indexed as

Adoptive TransferAmyloid Precursor Protein SecretasesAnimalsB7-1 AntigenCells, CulturedCoculture TechniquesEncephalomyelitis, Autoimmune, ExperimentalFemaleGene DeletionImmunoglobulin J Recombination Signal Sequence-Binding ProteinInterferon-gammaInterleukin-12 Subunit p40Interleukin-17Interleukin-6MacrophagesMiceAmyloid Precursor Protein SecretasesB7-1 AntigenImmunoglobulin J Recombination Signal Sequence-Binding ProteinInterferon-gammaInterleukin-12 Subunit p40Interleukin-17Interleukin-6Notch1 protein, mouseProto-Oncogene Proteins c-relRbpj protein, mouseReceptor, Notch1

Identifiers

PMID26503951
PMCPMC4691704
OpenAlexW1842424864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.